Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Moreau

Showing results (561-570 of 570) with videos related to

Pageof 57
Sort By:
You have reached the last page of results.This site can display upto 570 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2017
Second primary malignancies in multiple myeloma: an overview and IMWG consensusP Musto, K C Anderson, M Attal, et al.
Leukemia|June 5, 2009
International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantationA Palumbo, O Sezer, R Kyle, et al.
Leukemia|November 21, 2013
New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)E M Ocio, P G Richardson, S V Rajkumar, et al.
Leukemia|December 24, 2011
Management of treatment-emergent peripheral neuropathy in multiple myelomaP G Richardson, M Delforge, M Beksac, et al.
ESMO Open|March 10, 2022
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert ConsensusC Buske, M Dreyling, A Alvarez-Larrán, et al.
Archives of Gynecology and Obstetrics|October 4, 2016
E Wight, C Küng, P Moreau, et al.
Leukemia|January 5, 2013
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working GroupC Fernández de Larrea, R A Kyle, B G M Durie, et al.
Leukemia|December 30, 2015
Management of relapsed multiple myeloma: recommendations of the International Myeloma Working GroupJ Laubach, L Garderet, A Mahindra, et al.
Leukemia|June 17, 2017
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG studyS K Kumar, M A Dimopoulos, E Kastritis, et al.
Neuron|June 11, 2011
Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autismStephan J Sanders, A Gulhan Ercan-Sencicek, Vanessa Hus, et al.
Pageof 57

Showing results (561-570 of 570) with videos related to

Sort By:
Pageof 57
You have reached the last page of results.This site can display upto 570 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2017
Second primary malignancies in multiple myeloma: an overview and IMWG consensusP Musto, K C Anderson, M Attal, et al.
Leukemia|June 5, 2009
International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantationA Palumbo, O Sezer, R Kyle, et al.
Leukemia|November 21, 2013
New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)E M Ocio, P G Richardson, S V Rajkumar, et al.
Leukemia|December 24, 2011
Management of treatment-emergent peripheral neuropathy in multiple myelomaP G Richardson, M Delforge, M Beksac, et al.
ESMO Open|March 10, 2022
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert ConsensusC Buske, M Dreyling, A Alvarez-Larrán, et al.
Archives of Gynecology and Obstetrics|October 4, 2016
E Wight, C Küng, P Moreau, et al.
Leukemia|January 5, 2013
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working GroupC Fernández de Larrea, R A Kyle, B G M Durie, et al.
Leukemia|December 30, 2015
Management of relapsed multiple myeloma: recommendations of the International Myeloma Working GroupJ Laubach, L Garderet, A Mahindra, et al.
Leukemia|June 17, 2017
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG studyS K Kumar, M A Dimopoulos, E Kastritis, et al.
Neuron|June 11, 2011
Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autismStephan J Sanders, A Gulhan Ercan-Sencicek, Vanessa Hus, et al.
Pageof 57